19th March 2019 – Engineered Powders for Enhanced Pulmonary Delivery

News 19th March 2019 – Engineered Powder for Enhanced Pulmonary Delivery Upperton is continuing to invest in its combined spray drying and micronisation technology in order to meet increased demand. This emerging processing technology has been developed to enable the production of larger quantities of engineered powder formulations suitable for pulmonary delivery. The expansion of this service has … Read more

5th March 2019 – Analytical Techniques for Biotherapeutics

News 5th March 2019 – Analytical Techniques for Biotherapeutics Analysing Biotherapeutic Formulations There is growing interest in the use of spray drying to create biotherapeutic dry powder formulations. Spray drying is becoming increasingly viewed as a more cost-effective method for enhancing the stability of thermo-sensitive molecules (such as proteins, peptides, monoclonal antibodies and vaccines). A key … Read more

19th February 2019 – Biotherapeutic Formulation Development

News 19th February 2019 – Biotherapeutic Formulation Development Spray Drying Biotherapeutics Dry powder formulations of Biotherapeutics eliminate the need for expensive cold chain storage and facilitate supply chain management. Lyophilisation is traditionally used for the drying process, but in recent years the semi-continuous, robust and scalable qualities of spray drying have made it the drying … Read more

5th February 2019 – Extended Capabilities on Upperton’s non-GMP Pilot Plant

News 5th February 2019 – Non-GMP Pilot Plant Extended Capabilities Upperton Pharma Solutions now has a fully commissioned 60 square metre non-GMP pilot plant, mirroring our GMP manufacturing facility. The pilot plant is equipped for three scales of spray drying: ProCept 4M8-Trix for batch sizes of up to 300g Upperton Intermediate Spray Dryer for batch sizes … Read more

22nd January 2019 – Successful completion of EU Horizon 2020 Grant MACIVIVA

News 22nd January 2019 – Successful completion of EU Horizon 2020 Grant MACIVIVA In 2014, Upperton Pharma Solutions was awarded a prestigious Horizon 2020 MACIVIVA grant as part of a European consortium led by Mymetics, a pioneering company at the forefront of the development of virosome-based vaccines. The MACIVIVA goal was to develop dry powder, thermostable, … Read more

Let's Talk.

Book a discovery call.

To speak with a member of our team and talk about a project in more detail, set up a discovery call using the form opposite.

Do you want to accelerate your drug program?

Download our brochure to learn more about how our capabilities and delivery approach can help you.

Upperton Corporate Brochure